U.S. market Closed. Opens in 1 hour 10 minutes

FWBI | First Wave BioPharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue29.27K106.21K537.40K571.14K976.98KN/AN/AN/AN/A
Gross Profit-29.27K-106.21K-537.40K-571.14K-976.98KN/AN/AN/AN/A
Operating Expenses15.74M12.68M56.70M26.43M14.74M13.43M10.08M6.63M4.73M
Selling, General & Admin10.71M11.99M18.38M7.29M6.06M8.24M7.69M4.13M3.33M
Research & Development5.03M691.26K38.32M19.14M8.68M4.99M2.40M2.50M1.40M
Other Operating ExpensesN/A-232.74K529.10K211.43KN/A-210.00KN/AN/AN/A
Operating Income-15.77M-12.68M-59.06M-26.43M-14.74M-13.43M-10.22M-6.33M-4.73M
Other Expenses / Income-24.15K-1.95M519.04K-6.24M-433.94K-210.00K-875.20K-8.27M-1.20M
Before Tax Income-15.79M-14.63M-58.54M-32.67M-15.18M-13.53M-11.10M-14.59M-5.93M
Income Tax Expenses-4.001.95M540.34K6.05M433.94K-108.15KN/AN/AN/A
Net Income-15.79M-16.58M-59.08M-38.72M-15.61M-13.53M-11.10M-14.59M-5.93M
Interest Expenses-22.46K15.88K11.23K5.84M433.94K101.85K875.20K5.94M1.59M
Basic Shares Outstanding336.34K35.91K2.12K677.00533.007.35K5.06K650.48K963.11K
Diluted Shares Outstanding336.34K35.91K2.12K677.00533.007.35K5.06K650.48K963.11K
EBITDA-15.74M-12.87M-55.63M-25.66M-13.72M-12.63M-9.47M-5.89M-4.00M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-15.82M-14.61M-58.53M-26.83M-14.74M-13.54M-10.22M-8.65M-4.34M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙